AG真人官方

STOCK TITAN
  1. Home
  2. Sec-filings
  3. SDGR
  4. [SCHEDULE 13G/A] Schrodinger, Inc. SEC Filing

[SCHEDULE 13G/A] Schrodinger, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Filing content is currently unavailable.

Source:

Stock SDGR logo
Schrodinger, Inc.

NASDAQ:SDGR

SDGR Rankings

#2339 Ranked by Market Cap
N/A Ranked by Dividends
#67 Top Loser

SDGR Latest News

Aug 14, 2025
Schr枚dinger Announces Discontinuation of SGR-2921 Program
Aug 6, 2025
Schr枚dinger Reports Second Quarter 2025 Financial Results
Jul 25, 2025
Schr枚dinger to Announce Second Quarter 2025 Financial Results on August 6
Jul 18, 2025
Schr枚dinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Jul 17, 2025
Ajax Therapeutics and Schr枚dinger Expand Research Collaboration to Include Additional JAK Target

SDGR Latest SEC Filings

Aug 6, 2025
[8-K] Schrodinger, Inc. Reports Material Event
Jun 20, 2025
[Form 4] Schrodinger, Inc. Insider Trading Activity
Jun 20, 2025
[Form 4] Schrodinger, Inc. Insider Trading Activity
Jun 20, 2025
[Form 4] Schrodinger, Inc. Insider Trading Activity
Jun 20, 2025
[Form 4] Schrodinger, Inc. Insider Trading Activity

SDGR Stock Data

1.37B
62.74M
2.63%
101.77%
15.14%
Health Information Services
Pharmaceutical Preparations
United States
NEW YORK